Painchek Ltd (ASX:PCK)


right-arrow Created with Sketch. -0.001 (-1.75%)
MCAP $64.51M
Last trade 16.10pm 06/12/2021 20mins delayed

Latest Announcements

03/12/2021PCKPainchek Ltd
30/11/2021PCKPainchek Ltd
30/11/2021 Price SensitivePSPCKPainchek Ltd
30/11/2021PCKPainchek Ltd
22/11/2021PCKPainchek Ltd
27/10/2021PCKPainchek Ltd
27/10/2021PCKPainchek Ltd
22/10/2021 Price SensitivePSPCKPainchek Ltd

Company Overview

PainChek Limited is an Australia-based company, that develops pain assessment technologies. The Company’s principal activities are development and commercialization of mobile medical device applications, that automate intelligent pain assessment of individuals who are unable to communicate their pain with carers. Its Paincheck is an Adult and Infant pain assessment applications. Its PainChek technology uses cameras in smartphones and tablets to capture a brief video of the person, which is analyzed in real time using facial recognition software to detect the presence of facial micro-expressions that are indicative of the presence of pain. Its Paincheck uses artificial intelligence (AI) to automatically assess the micro-facial features of pain. Its PainChek technology has multiple regulatory clearances, including TGA (Australia) and CE Mark (Europe) for use as a class 1 medical device to assess pain in people who are unable to reliably verbalize, such people with dementia.

PCK in the news

PainChek (PCK) is set to receive a $1.25 million cash injection from…
PainChek (PCK) has received CE Mark and UK MHRA clearances to start…
PainChek (PCK) has delivered yet another quarter of positive growth for its…
PainChek (PCK) has received CE Mark and Therapeutic Goods Administration (TGA) clearance…

Search Previous Announcements